LUIS GONZAGA
PAZ-ARES RODRÍGUEZ
Profesor titular de universidad
University of Pennsylvania
Filadelfia, Estados UnidosPublicaciones en colaboración con investigadores/as de University of Pennsylvania (3)
2022
-
Long-Term Efficacy and Safety of Brigatinib in Crizotinib-Refractory ALK+ NSCLC: Final Results of the Phase 1/2 and Randomized Phase 2 (ALTA) Trials
JTO Clinical and Research Reports, Vol. 3, Núm. 9
2017
-
Safety Analyses of Pemetrexed-cisplatin and Pemetrexed Maintenance Therapies in Patients With Advanced Non-squamous NSCLC: Retrospective Analyses From 2 Phase III Studies
Clinical Lung Cancer, Vol. 18, Núm. 5, pp. 489-496
2009
-
Safety, pharmacokinetics, and pharmacodynamics of the insulin-like growth factor type 1 receptor inhibitor figitumumab (CP-751,871) in combination with paclitaxel and carboplatin
Journal of Thoracic Oncology, Vol. 4, Núm. 11, pp. 1397-1403